Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Sumitomo Dainippon Pharma Co (DNPUF) vs. Competitors

10 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DNPUFSumitomo Dainippon Pharma Co$12.21$5.68B18.92-6.08%Moderate BuyUnlock the DNPUF analyst price target with TipRanks PremiumDNPUFUnlock the DNPUF top-analyst price target with TipRanks Premium
JP:4523Eisai CoJPY 5,296.00JPY 1.49T33.9513.28%―Unlock the JP:4523 analyst price target with TipRanks PremiumDNPUF vs JP:4523Unlock the JP:4523 top-analyst price target with TipRanks Premium
JP:4547Kissei Pharmaceutical CoJPY 4,400.00JPY 159.71B14.515.26%HoldUnlock the JP:4547 analyst price target with TipRanks PremiumDNPUF vs JP:4547Unlock the JP:4547 top-analyst price target with TipRanks Premium
JP:4507Shionogi & CoJPY 3,188.00JPY 2.85T11.4318.73%Moderate BuyUnlock the JP:4507 analyst price target with TipRanks PremiumDNPUF vs JP:4507Unlock the JP:4507 top-analyst price target with TipRanks Premium
JP:4502Takeda Pharmaceutical CoJPY 6,931.00JPY 11.07T28.3358.53%Strong BuyUnlock the JP:4502 analyst price target with TipRanks PremiumDNPUF vs JP:4502Unlock the JP:4502 top-analyst price target with TipRanks Premium
JP:4516Nippon Shinyaku Co., Ltd.JPY 3,423.00JPY 232.57B7.90-3.47%HoldUnlock the JP:4516 analyst price target with TipRanks PremiumDNPUF vs JP:4516Unlock the JP:4516 top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DNPUFSumitomo Dainippon Pharma Co12.21-0.79-6.08%
JP:4523Eisai Co5296.00864.0819.50%
JP:4547Kissei Pharmaceutical Co4400.00384.849.58%
JP:4507Shionogi & Co3188.00546.1120.67%
JP:4502Takeda Pharmaceutical Co6931.002732.8965.10%
JP:4516Nippon Shinyaku Co., Ltd.3423.000.200.01%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts